-+ 0.00%
-+ 0.00%
-+ 0.00%

Needham Maintains Buy on Insight Molecular, Raises Price Target to $9

Benzinga·11/11/2025 11:01:32
Listen to the news
Needham analyst Mike Matson maintains Insight Molecular (NASDAQ:IMDX) with a Buy and raises the price target from $4.25 to $9.